TrialDrug design, development and therapy2019

Single- and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects.

Patricia N Sidharta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.